Agios Pharmaceuticals (AGIO) Asset Utilization Ratio (2013 - 2026)

Agios Pharmaceuticals' Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.05 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 131.25% year-over-year to 0.05 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.05 (up 131.25% YoY) and the FY2025 annual result came in at 0.04, up 30.02% from the prior year.
• Asset Utilization Ratio was 0.05 for Q1 2026 at Agios Pharmaceuticals, up from 0.04 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.05 in Q1 2026 and bottomed at 0.0 in Q1 2022.
• A 5-year average of 0.02 and a median of 0.02 in 2025 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio sank 99.14% — and 2023, when it soared 2552.53%.
• Agios Pharmaceuticals' Asset Utilization Ratio stood at 0.01 in 2022, then surged by 134.35% to 0.03 in 2023, then declined by 23.42% to 0.02 in 2024, then jumped by 90.63% to 0.04 in 2025, then jumped by 32.13% to 0.05 in 2026.
• Business Quant data shows AGIO's Asset Utilization Ratio at 0.05 in Q1 2026, 0.04 in Q4 2025, and 0.03 in Q3 2025.